Home > Insider Trading > Filing (0001415889-23-006696)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1070081	Ptc Therapeutics Inc.	PTCT	Pharmaceutical Preparations (2834)	043416587

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1251553	P David Southwell	C/O Ptc Therapeutics, Inc. 100 Corporate Court South Plainfield NJ 07080		No	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2023-04-17	11,429	$18.01	21,929	No	4	M	Direct
Common Stock	Disposition	2023-04-17	6,241	$50.69	15,688	No	4	S	Direct
Common Stock	Disposition	2023-04-17	5,188	$51.43	10,500	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2023-04-17	11,429	$18.01	11,429	$18.01

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2028-01-02	No	4	M	Direct

Reported Derivative Holdings

Sec. Name	Sec. Type	Price	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock	Stock Option (Right to Buy)	$51.00	2025-01-02	12,000	12,000	Direct
Common Stock	Stock Option (Right to Buy)	$30.86	2026-01-03	12,000	12,000	Direct
Common Stock	Stock Option (Right to Buy)	$33.02	2029-01-02	14,000	14,000	Direct
Common Stock	Stock Option (Right to Buy)	$51.16	2030-01-28	10,000	10,000	Direct
Common Stock	Stock Option (Right to Buy)	$66.49	2031-01-05	10,000	10,000	Direct
Common Stock	Stock Option (Right to Buy)	$38.10	2032-01-06	12,000	12,000	Direct
Common Stock	Stock Option (Right to Buy)	$39.42	2033-01-04	10,000	10,000	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2025-01-02	12,000	12,000	Direct
2026-01-03	12,000	12,000	Direct
2029-01-02	14,000	14,000	Direct
2030-01-28	10,000	10,000	Direct
2031-01-05	10,000	10,000	Direct
2032-01-06	12,000	12,000	Direct
2033-01-04	10,000	10,000	Direct

Footnotes

This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on February 24, 2023.
This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $50.00 to $50.97 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $51.01 to $51.835 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Currently exercisable.
This option was granted on January 5, 2023 and vests over one year in twelve equal monthly installments, commencing on February 5, 2023.